UNSPSC 41202014: Coxsackievirus serological reagents

In this classification, Coxsackievirus serological reagents are devices used in test to identify specific Coxsackievirus antibodies in serum. US FDA regulates Coxsackievirus serological reagents under 21 CFR 866.3145 and under FDA product code GNG.

UNSPSC 41202014 Coxsackievirus serological reagents (Commodity) encompasses diagnostic testing reagents and supplies used by state and local health departments, correctional agencies, and public health laboratories for infectious disease screening and surveillance. Recent state and local solicitations show the code is being applied broadly to sexually transmitted infection testing kits, HIV test kits, HIV and syphilis reagents, and drug testing supplies — a scope that extends well beyond coxsackievirus reagents alone to cover general clinical and forensic laboratory diagnostics. The issuing bodies include state health departments (Illinois Department of Public Health, Texas Department of Criminal Justice), county health services and correctional agencies (Collin County Community Supervision and Corrections Department, Collin County Health Care Services, Gwinnett County), and municipal public health programs (City of Austin). State health departments emerge as repeat buyers, with the Illinois Department of Public Health conducting multiple emergency procurements for Abbott HIV and syphilis reagents and a change order to increase sexually transmitted infection testing volumes under an existing Hologic testing platform contract.

Geographic activity concentrates in Texas and Illinois. Representative recent opportunities include the Illinois Department of Public Health's change order (IFB, October 13, 2026 response deadline) to increase annual NG/CT testing from 15,000 to 25,000 tests and collection kits from 15,000 to 30,000 units, raising the five-year contract cost by $375,000 to a revised total of $900,000; Collin County Community Supervision and Corrections Department's RFP (July 23, 2026 response deadline) for offender specimen collection and drug testing services at approximately 25,031 annual tests with an estimated contract value of $600,000; the City of Austin's IFB for Abbott Determine HIV test kits (September 3, 2026 response deadline, rebid) supporting 375 annual kits and 79 control kits; and Collin County Health Care Services' IFB for comprehensive laboratory services processing over 200 test types with an estimated annual value of $70,000. The Illinois Department of Public Health also conducted an emergency sole-source procurement to Abbott Laboratories for HIV and syphilis reagents ($38,079.50) and filed final costs for an earlier emergency Abbott reagent purchase.